On Thursday, an FDA advisory panel voted 17 to 4, with one abstention, in favor of authorizing the vaccine, which was shown to be 95% effective in a large clinical trial. While, if often follows the panel’s recommendations, the agency itself has final say in whether to grant the authorization.

Source link

By admin

Leave a Reply

Your email address will not be published. Required fields are marked *